Evidence map›Paper›PMID 34779648›Full record

ArticleBioanalysis2021

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China.

Hongran Li, Tong Jiao, Peirong Wang, Juanjuan An, Gang Deng, Lei Sun, Jinchun Dong

Abstract readTechnical Report
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioanalysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongran LiCenter for Medical Device Evaluation, NMPA, 50 Qixiang Road, Haidian District, Beijing, 100081, China.
Tong JiaoCenter for Medical Device Evaluation, NMPA, 50 Qixiang Road, Haidian District, Beijing, 100081, China.
Peirong WangCenter for Medical Device Evaluation, NMPA, 50 Qixiang Road, Haidian District, Beijing, 100081, China.ORCID 0000-0002-7736-9389
Juanjuan AnCenter for Medical Device Evaluation, NMPA, 50 Qixiang Road, Haidian District, Beijing, 100081, China.
Gang DengCenter for Medical Device Evaluation, NMPA, 50 Qixiang Road, Haidian District, Beijing, 100081, China.
Lei SunCenter for Medical Device Evaluation, NMPA, 50 Qixiang Road, Haidian District, Beijing, 100081, China.
Jinchun DongCenter for Medical Device Evaluation, NMPA, 50 Qixiang Road, Haidian District, Beijing, 100081, China.

Funding

Ministry of Science and Technology of the People's Republic of China 2020YFC0841200
6 · The paper itself

Abstract

In response to the outbreak of COVID-19, in accordance with the principles of 'unified command, early involvement, prompt review and scientific approval' as well as the requirements of ensuring product safety, effectiveness and controllable quality, the Center for Medical Device Evaluation (CMDE) has issued

Indexed as

ChinaCOVID-19 Nucleic Acid TestingHumansSARS-CoV-2nucleic acidregistrationSARS-CoV-2tests

Identifiers

PMID34779648
PMCPMC8597659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.